A multidisciplinary approach to coronavirus disease (COVID-19)
View/ Open
Access
info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Date
2021Author
Gediz Ertürk, AliyeŞahin, Arzu
Batı Ay, Ebru
Pelit, Emel
Bağdatlı, Emine
Kulu, İrem
Gül, Melek
Mesci, Seda
Eryılmaz, Serpil
Oba İlter, Şirin
Yıldırım, Tuba
Metadata
Show full item recordCitation
Gediz Ertürk, A., Şahin, A., Batı Ay, E., Pelit, E., Bağdatlı, Kulu, İ., Gül, M., Mesci, S., Eryılmaz, S., Oba İlter, S. & Yıldırım, T. (2021). A multidisciplinary approach to coronavirus disease (COVID-19). Molecules, 26 (12), 3526.Abstract
Since December 2019, humanity has faced an important global threat. Many studies have been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus and the treatment of its disease. The priority of scientists all over the world has been to direct their time to research this subject. In this review, we highlight chemical studies and therapeutic approaches to overcome COVID-19 with seven different sections. These sections are the structure and mechanism of action of SARS-CoV-2, immunotherapy and vaccine, computer-aided drug design, repurposing therapeutics for COVID-19, synthesis of new molecular structures against COVID-19, food safety/security and functional food components, and potential natural products against COVID-19. In this work, we aimed to screen all the newly synthesized compounds, repurposing chemicals covering antiviral, anti-inflammatory, antibacterial, antiparasitic, anticancer, antipsychotic, and antihistamine compounds against COVID-19. We also highlight computer-aided approaches to develop an anti-COVID-19 molecule. We explain that some phytochemicals and dietary supplements have been identified as antiviral bioproducts, which have almost been successfully tested against COVID-19. In addition, we present immunotherapy types, targets, immunotherapy and inflammation/mutations of the virus, immune response, and vaccine issues.